Dario Eklund
Chief Executive Officer at SANTHERA PHARMACEUTICALS HOLDING AG
Net worth: 25 241 $ as of 30/04/2024
Dario Eklund active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Chief Executive Officer | 01/12/2019 | - |
| Investor Relations Contact | - | - | |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vifor Fresenius Medical Care Renal Pharma Ltd. engages in the research in as well as development, marketing, and distribution of pharmaceutical products used in the field of nephrology for the treatment of patients suffering from chronic kidney disease. It offers products specialized in anemia, mineral, bone, and cardio-renal management. The company was founded on November 26, 2010 and is headquartered in St. Gallen, Switzerland. | Director/Board Member | - | - |
Career history of Dario Eklund
Former positions of Dario Eklund
| Companies | Position | Start | End |
|---|---|---|---|
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Corporate Officer/Principal | 01/01/2014 | 30/09/2019 |
| VIFOR PHARMA | Corporate Officer/Principal | 01/01/2014 | 30/09/2019 |
| SANOFI | Corporate Officer/Principal | 01/01/2002 | 01/01/2004 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/1994 | 01/01/2002 |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Corporate Officer/Principal | - | - |
| Aventis Pharma AG | Corporate Officer/Principal | - | - |
Training of Dario Eklund
| Hanken Svenska Handelshögskolan | Graduate Degree |
Statistics
International
| Switzerland | 6 |
| Finland | 2 |
| Germany | 2 |
Operational
| Corporate Officer/Principal | 6 |
| Graduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| SANOFI | Health Technology |
| Private companies | 5 |
|---|---|
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Health Technology |
| Aventis Pharma AG | |
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vifor Fresenius Medical Care Renal Pharma Ltd. engages in the research in as well as development, marketing, and distribution of pharmaceutical products used in the field of nephrology for the treatment of patients suffering from chronic kidney disease. It offers products specialized in anemia, mineral, bone, and cardio-renal management. The company was founded on November 26, 2010 and is headquartered in St. Gallen, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Dario Eklund
- Experience
